NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/17/2025
Back to search
Official data from USPTO
D3 BIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
06/17/2025
Trademark type
Combined
Nice classes
5
Filing date
04/22/2021
Registration date
06/17/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/17/2025
Last transaction
06/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
99
Owner location
Jiangsu Province, CN
Examiner
SANCHEZ RIVERA, MARIA C.
Law office
M30
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the words "D3 BIO" in black all caps below three Chinese characters in red, all to the right of a rounded red zig-zag design centered on a red vertical line.
Holders and representatives
Holders
D3 Bio (Wuxi) Co., Ltd.
Representatives
JOHN PAUL OLEKSIUK COOLEY LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of respiratory diseasescancermusculoskeletal diseasesgastrointestinal diseasediseases and disorders related to the immune systemcentral nervous systemcardiovascular system; chemico-pharmaceutical preparations for the treatment of respiratory diseasescancermusculoskeletal diseasesgastrointestinal diseasediseases and disorders related to the immune systemcentral nervous systemcardiovascular system; drugs for medical purposes; pharmaceutical preparations for use in biomedicine; pharmaceutical drugs for the treatment of respiratory diseases; pharmaceutical drugs for the treatment of cancer; pharmaceutical preparation for treating musculoskeletal disorders; pharmaceutical preparation for treating gastrointestinal disease; pharmaceutical preparation for treating diseases and disorders related to the immune system; pharmaceutical preparation for the central nervous system; cardiovascular pharmaceutical drug preparation; none of the foregoing related to diagnostic preparationsdiagnostic reagentsdiagnostic screening kits
Publications
History of USPTO decisions and trademark events.
33 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/17/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/29/2025
PUBO
PUBLISHED FOR OPPOSITION
04/29/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/23/2025
EXPT
EXPARTE APPEAL TERMINATED
04/01/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/01/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
03/31/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/31/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
03/31/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/31/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/17/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/17/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/14/2024
EXPI
EX PARTE APPEAL-INSTITUTED
10/14/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
10/14/2024
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
10/14/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
07/29/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
07/29/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/29/2024
GNFR
FINAL REFUSAL E-MAILED
04/29/2024
CNFR
FINAL REFUSAL WRITTEN
04/29/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/25/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/25/2022
ALIE
ASSIGNED TO LIE
07/23/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/05/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/05/2022
GNRT
NON-FINAL ACTION E-MAILED
01/05/2022
CNRT
NON-FINAL ACTION WRITTEN
01/05/2022
DOCK
ASSIGNED TO EXAMINER
12/17/2021
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/29/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/28/2021
NWAP
NEW APPLICATION ENTERED
04/26/2021
Continuous trademark protection
Get notified about every new filing that threatens D3 BIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.